ClinicalTrials.Veeva

Menu

Innovative Ultrasound Technology in Neuromuscular Disease (AQUIRe)

Beth Israel Lahey Health logo

Beth Israel Lahey Health

Status

Completed

Conditions

Orthopedic Disorder
Myopathy
Radiculopathy
Trauma Injury
Amyotrophic Lateral Sclerosis
Muscular Dystrophy
Polyneuropathy and Mononeuropathies

Study type

Observational

Funder types

Other
NIH

Identifiers

NCT02104921
2K24NS060951 (U.S. NIH Grant/Contract)
2012P000364

Details and patient eligibility

About

This study is utilizing ultrasound measurement to measure neuromuscular disease status in adult patients. The hypothesis is the by quantifying ultrasound data, it is possible that ultrasound can be utilized as a tool to determine if a disease is responding to therapy or progressing.

Enrollment

223 patients

Sex

All

Ages

18 to 90 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • History of a well-defined, localized or generalized neuromuscular condition producing weakness or muscle atrophy, including disuse atrophy.

Exclusion criteria

  • Multiple generalized neuromuscular conditions.

Trial design

223 participants in 2 patient groups

Neuromuscular Disease Patients
Description:
Amyotrophic lateral sclerosis patients, myopathy patients, muscular dystrophy patients, myasthenia gravis patients, radiculopathy patients, mononeuropathy patients
Healthy volunteers

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems